Clinical Outcomes and Healthcare Costs of <scp>CART</scp> Versus Paracentesis for Malignant Ascites: A Nationwide Retrospective Cohort Study in Japan
CART was associated with improved clinical outcomes and healthcare costs over paracentesis among hospitalized patients with metastatic cancer, particularly in males, patients with serum albumin ≤ 2.5 g/dL, and those with non-gastrointestinal cancer. These findings may support clinical decision-making and resource allocation.
Authors
- Norihiko Inoue (ORCID: https://orcid.org/0000-0001-9187-371X)
- Shinobu Imai (ORCID: https://orcid.org/0000-0003-1784-5133)
- Yuki Hashimoto
Institutions
- SHOWA Medical University (JP)
- Japan Clinical Cancer Research Organization (JP)
- Showa Pharmaceutical University (JP)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-12-26
- DOI
- https://doi.org/10.1002/cam4.71491
- Primary Topic
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Society for the Promotion of Science